Cara L. Croft

1.1k total citations
18 papers, 603 citations indexed

About

Cara L. Croft is a scholar working on Physiology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Cara L. Croft has authored 18 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 9 papers in Cellular and Molecular Neuroscience and 8 papers in Neurology. Recurrent topics in Cara L. Croft's work include Alzheimer's disease research and treatments (14 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Cara L. Croft is often cited by papers focused on Alzheimer's disease research and treatments (14 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Cara L. Croft collaborates with scholars based in United States, United Kingdom and Australia. Cara L. Croft's co-authors include Todd E. Golde, Diane P. Hanger, Wendy Noble, Ksenia Kurbatskaya, Hunter S. Futch, Benoit I. Giasson, Emma Claire Phillips, Paramita Chakrabarty, Kevin H. Strang and Brenda D. Moore and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and PLoS ONE.

In The Last Decade

Cara L. Croft

18 papers receiving 598 citations

Peers

Cara L. Croft
Bridget Allen United Kingdom
Yan Jouroukhin United States
James P. Quinn United States
Olga Petrova Germany
Sarah M. Neuner United States
Maria Fe Lanfranco United States
Grace O. Robinson United States
Bridget Allen United Kingdom
Cara L. Croft
Citations per year, relative to Cara L. Croft Cara L. Croft (= 1×) peers Bridget Allen

Countries citing papers authored by Cara L. Croft

Since Specialization
Citations

This map shows the geographic impact of Cara L. Croft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cara L. Croft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cara L. Croft more than expected).

Fields of papers citing papers by Cara L. Croft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cara L. Croft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cara L. Croft. The network helps show where Cara L. Croft may publish in the future.

Co-authorship network of co-authors of Cara L. Croft

This figure shows the co-authorship network connecting the top 25 collaborators of Cara L. Croft. A scholar is included among the top collaborators of Cara L. Croft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cara L. Croft. Cara L. Croft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Croft, Cara L., Agnes L. Nishimura, Claire Troakes, et al.. (2024). Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection. Science Advances. 10(12). eadk9884–eadk9884. 13 indexed citations
2.
Hughes, Martina M., Claire Troakes, Cara L. Croft, et al.. (2023). P2X7R influences tau aggregate burden in human tauopathies and shows distinct signalling in microglia and astrocytes. Brain Behavior and Immunity. 114. 414–429. 10 indexed citations
3.
Croft, Cara L., Daniel Ryu, Marshall S. Goodwin, et al.. (2022). Optical pulse labeling studies reveal exogenous seeding slows α-synuclein clearance. npj Parkinson s Disease. 8(1). 173–173. 1 indexed citations
4.
Xia, Yuxing, Stefan Prokop, Kimberly-Marie M. Gorion, et al.. (2022). Pathogenic tau recruits wild-type tau into brain inclusions and induces gut degeneration in transgenic SPAM mice. Communications Biology. 5(1). 446–446. 13 indexed citations
5.
Moore, Brenda D., Yona Levites, Guilian Xu, et al.. (2022). Soluble brain homogenates from diverse human and mouse sources preferentially seed diffuse Aβ plaque pathology when injected into newborn mouse hosts. PubMed. 3(9). 9–9. 2 indexed citations
6.
Croft, Cara L., Marshall S. Goodwin, Daniel Ryu, et al.. (2021). Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions. Acta Neuropathologica. 141(3). 359–381. 15 indexed citations
7.
Croft, Cara L., Xuefei Liu, Daniel Ryu, et al.. (2020). Elucidating the relationship between TGF‐β signaling and Alzheimer’s disease. Alzheimer s & Dementia. 16(S2). 2 indexed citations
8.
Croft, Cara L., Hunter S. Futch, Brenda D. Moore, & Todd E. Golde. (2019). Organotypic brain slice cultures to model neurodegenerative proteinopathies. Molecular Neurodegeneration. 14(1). 45–45. 71 indexed citations
9.
Croft, Cara L., Pedro E. Cruz, Daniel Ryu, et al.. (2019). rAAV-based brain slice culture models of Alzheimer’s and Parkinson’s disease inclusion pathologies. The Journal of Experimental Medicine. 216(3). 539–555. 35 indexed citations
10.
Croft, Cara L., Brenda D. Moore, Yong Ran, et al.. (2018). Novel monoclonal antibodies targeting the microtubule-binding domain of human tau. PLoS ONE. 13(4). e0195211–e0195211. 10 indexed citations
11.
Croft, Cara L., Ksenia Kurbatskaya, Martina M. Hughes, et al.. (2017). Membrane association and release of wild-type and pathological tau from organotypic brain slice cultures. Cell Death and Disease. 8(3). e2671–e2671. 41 indexed citations
12.
Croft, Cara L., Ksenia Kurbatskaya, Diane P. Hanger, & Wendy Noble. (2017). Inhibition of glycogen synthase kinase-3 by BTA-EG4 reduces tau abnormalities in an organotypic brain slice culture model of Alzheimer’s disease. Scientific Reports. 7(1). 7434–7434. 14 indexed citations
13.
Futch, Hunter S., et al.. (2017). Targeting psychologic stress signaling pathways in Alzheimer’s disease. Molecular Neurodegeneration. 12(1). 49–49. 42 indexed citations
14.
Strang, Kevin H., Cara L. Croft, Zachary A. Sorrentino, et al.. (2017). Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies. Journal of Biological Chemistry. 293(7). 2408–2421. 99 indexed citations
15.
Kurbatskaya, Ksenia, Emma Claire Phillips, Cara L. Croft, et al.. (2016). Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain. Acta Neuropathologica Communications. 4(1). 34–34. 89 indexed citations
16.
Hughes, Alun T. L., et al.. (2015). Constant light enhances synchrony among circadian clock cells and promotes behavioral rhythms in VPAC2-signaling deficient mice. Scientific Reports. 5(1). 14044–14044. 22 indexed citations
17.
Phillips, Emma Claire, Cara L. Croft, Ksenia Kurbatskaya, et al.. (2014). Astrocytes and neuroinflammation in Alzheimer's disease. Biochemical Society Transactions. 42(5). 1321–1325. 86 indexed citations
18.
Atherton, Joseph, Ksenia Kurbatskaya, Marie K. Bondulich, et al.. (2013). Calpain cleavage and inactivation of the sodium calcium exchanger‐3 occur downstream of Aβ in Alzheimer's disease. Aging Cell. 13(1). 49–59. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026